Safety and Tolerability of Subretinal OPGx-RDH12-1001 for LCA-Associated Inherited Retinal Degeneration (LCA-IRD)
Safety and Tolerability of Subretinal OPGx-RDH12-1001 for LCA-Associated Inherited Retinal Degeneration (LCA-IRD)
Not yet recruiting · NCT07681778 · Registry updated 2026-07-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Tolerability of Subretinal OPGx-RDH12-1001 for LCA-Associated Inherited Retinal Degeneration (LCA-IRD) | Eye Diseases, Hereditary, Leber congenital amaurosis, eye disorder, retinal disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-07-15 | NCT07681778 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Opus Genetics, Inc | 3 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Associated Retina Consultants | Phoenix | United States | 21 |
| Perelman School of Medicine, University of Pennsylvania | Philadelphia | United States | 1 |
| Retina Consultants of Texas & Retina Group Inc. | Houston | United States | 1 |